NT5C3B
7-methylguanosine phosphate-specific 5'-nucleotidase · Q969T7 · NT5C3B on Sugi Atlas →
8 patent compounds predicted against NT5C3B, 6 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours | |
|---|---|---|---|
| SCHEMBL29438538 | 0.64 | 1/20 | |
| SCHEMBL29466648 | 0.62 | 1/20 | |
| SCHEMBL29824509 | 0.61 | 1/20 | |
| SCHEMBL31122854 | 0.61 | 1/20 | |
| SCHEMBL29390254 | 0.60 | 1/20 | |
| SCHEMBL29352966 | 0.46 | 1/20 |
Clinical trials — most relevant to NT5C3B by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a NT5C3B binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| Q3UFY7 | — | 1.000 | Q3UFY7 → |
| Q6AYP7 | — | 0.997 | Q6AYP7 → |
| Q9H0P0 | — | 0.981 | Q9H0P0 → |
| Q9D020 | — | 0.981 | Q9D020 → |
| Q7SYN4 | — | 0.980 | Q7SYN4 → |
| Q5ZKF6 | — | 0.975 | Q5ZKF6 → |
| Q5ZID6 | — | 0.971 | Q5ZID6 → |
| Q5PPH0 | — | 0.960 | Q5PPH0 → |
| Q8K183 | — | 0.958 | Q8K183 → |
| O35621 | — | 0.958 | O35621 → |
| Q4R4U1 | — | 0.956 | Q4R4U1 → |
| Q5R5F8 | — | 0.954 | Q5R5F8 → |
| PMM2 | Phosphomannomutase 2 | 0.954 | landscape → |
| PDXK | Pyridoxal kinase | 0.954 | landscape → |
| Q923S8 | — | 0.954 | Q923S8 → |
| Q91YD4 | — | 0.954 | Q91YD4 → |
| Q9NVE7 | — | 0.953 | Q9NVE7 → |
| Q60HD6 | — | 0.953 | Q60HD6 → |
| O35331 | — | 0.953 | O35331 → |
| A0A0U1WZ18 | — | 0.952 | A0A0U1WZ18 → |
| Q92871 | — | 0.951 | Q92871 → |
| B1H369 | — | 0.951 | B1H369 → |
| P82197 | — | 0.950 | P82197 → |
| Q3SZJ9 | — | 0.950 | Q3SZJ9 → |
| TRPM2 | Transient receptor potential cation channel subfamily M member 2 | 0.949 | landscape → |
| E9PTA2 | — | 0.949 | E9PTA2 → |
| Q9QZ08 | — | 0.949 | Q9QZ08 → |
| O46560 | — | 0.948 | O46560 → |
| Q6DC64 | — | 0.948 | Q6DC64 → |
| Q0II59 | — | 0.948 | Q0II59 → |